Market revenue in 2023 | USD 0.3 million |
Market revenue in 2030 | USD 1.0 million |
Growth rate | 17.7% (CAGR from 2023 to 2030) |
Largest segment | Neurology |
Fastest growing segment | Orthopedic |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Dental, Orthopedic, Neurology |
Key market players worldwide | GlaxoSmithKline, Hewlett Packard Enterprise Co, Merck KGaA, AstraZeneca PLC, Aprecia Pharmaceuticals, Extend Biosciences, BioDuro, Affini-T Therapeutics, Osmotica Pharmaceutical, FabRx, Cycle Pharmaceuticals |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to 3d printed drugs market will help companies and investors design strategic landscapes.
Neurology was the largest segment with a revenue share of 66.67% in 2023. Horizon Databook has segmented the Thailand 3d printed drugs market based on dental, orthopedic, neurology covering the revenue growth of each sub-segment from 2018 to 2030.
Thailand's 3D printed drugs market is growing due to the nation's proactive approach to adopting innovative healthcare solutions. The Thai government's initiatives to boost its healthcare system and encourage R&D in pharmaceuticals have created a favorable environment for integrating 3D printing technology.
For instance, in April 2021, the Thailand Board of Investment (BOI) announced the approval of fresh projects in the advanced biotechnology sector, with a total investment of approximately THB 2.4 billion. This approval highlights the growth of both domestic & international investments in the country's biotechnology industry.
Moreover, the cost-effectiveness and flexibility of 3D printing in drug manufacturing align with Thailand's healthcare objectives, especially in personalized medicine and addressing specific patient requirements. Furthermore, partnerships between academia, industry players, and government agencies contribute to the growth of 3D printed drug technologies in the country.
Horizon Databook provides a detailed overview of country-level data and insights on the Thailand 3d printed drugs market , including forecasts for subscribers. This country databook contains high-level insights into Thailand 3d printed drugs market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account